199 related articles for article (PubMed ID: 36470870)
1. USP36 facilitates esophageal squamous carcinoma progression via stabilizing YAP.
Zhang W; Luo J; Xiao Z; Zang Y; Li X; Zhou Y; Zhou J; Tian Z; Zhu J; Zhao X
Cell Death Dis; 2022 Dec; 13(12):1021. PubMed ID: 36470870
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
3. DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer.
Wang D; Li Z; Li X; Yan C; Yang H; Zhuang T; Wang X; Zang Y; Liu Z; Wang T; Jiang R; Su P; Zhu J; Ding Y
J Exp Clin Cancer Res; 2022 Jul; 41(1):219. PubMed ID: 35820928
[TBL] [Abstract][Full Text] [Related]
4. RNF106 aggravates esophageal squamous cell carcinoma progression through LATS2/YAP axis.
Sun Q; Lu H; Zhang W; Du Y; Liang Q; Zhang Y; Wu J; Zhong M
Arch Biochem Biophys; 2023 Jul; 742():109640. PubMed ID: 37207933
[TBL] [Abstract][Full Text] [Related]
5. SHARPIN Inhibits Esophageal Squamous Cell Carcinoma Progression by Modulating Hippo Signaling.
Zhang A; Wang W; Chen Z; Pang D; Zhou X; Lu K; Hou J; Wang S; Gao C; Lv B; Yan Z; Chen Z; Zhu J; Wang L; Zhuang T; Li X
Neoplasia; 2020 Feb; 22(2):76-85. PubMed ID: 31884247
[TBL] [Abstract][Full Text] [Related]
6. RGS16 regulates Hippo-YAP activity to promote esophageal cancer cell proliferation and migration.
Zhang Y; Zhu Q; Cao X; Ni B
Biochem Biophys Res Commun; 2023 Oct; 675():122-129. PubMed ID: 37473526
[TBL] [Abstract][Full Text] [Related]
7. RACO-1 modulates Hippo signalling in oesophageal squamous cell carcinoma.
Pang D; Wang W; Zhou X; Lu K; Zhang J; Chen Z; Wang L; Shen F; Chen Z; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Hu Y; Chang T; Wang L; Li X
J Cell Mol Med; 2020 Oct; 24(20):11912-11921. PubMed ID: 32896069
[TBL] [Abstract][Full Text] [Related]
8. The Hippo-YAP signaling pathway drives CD24-mediated immune evasion in esophageal squamous cell carcinoma via macrophage phagocytosis.
Zhou X; Yan Z; Hou J; Zhang L; Chen Z; Gao C; Ahmad NH; Guo M; Wang W; Han T; Chang T; Kang X; Wang L; Liang Y; Li X
Oncogene; 2024 Feb; 43(7):495-510. PubMed ID: 38168654
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinase USP8 increases ID1 stability and promotes esophageal squamous cell carcinoma tumorigenesis.
Li L; Liu Y; Zhao Y; Feng R; Li Y; Yu X; Liu Z; Wang L
Cancer Lett; 2022 Aug; 542():215760. PubMed ID: 35636624
[TBL] [Abstract][Full Text] [Related]
10. OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer.
Yan C; Yang H; Su P; Li X; Li Z; Wang D; Zang Y; Wang T; Liu Z; Bao Z; Dong S; Zhuang T; Zhu J; Ding Y
Oncogene; 2022 Nov; 41(48):5186-5198. PubMed ID: 36271031
[TBL] [Abstract][Full Text] [Related]
11. Autocrine Leukemia Inhibitory Factor Promotes Esophageal Squamous Cell Carcinoma Progression via Src Family Kinase-Dependent Yes-Associated Protein Activation.
Kawazoe T; Saeki H; Oki E; Oda Y; Maehara Y; Mori M; Taniguchi K
Mol Cancer Res; 2020 Dec; 18(12):1876-1888. PubMed ID: 33004621
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA MALAT1 promotes the stemness of esophageal squamous cell carcinoma by enhancing YAP transcriptional activity.
Yao Q; Yang J; Liu T; Zhang J; Zheng Y
FEBS Open Bio; 2019 Aug; 9(8):1392-1402. PubMed ID: 31116509
[TBL] [Abstract][Full Text] [Related]
13. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.
Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW
Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576
[TBL] [Abstract][Full Text] [Related]
14. Chaetocin exhibits anticancer effects in esophageal squamous cell carcinoma via activation of Hippo pathway.
Li L; Jiang H; Li Y; Xiang X; Chu Y; Tang J; Liu K; Huo D; Zhang X
Aging (Albany NY); 2023 Jun; 15(12):5426-5444. PubMed ID: 37319316
[TBL] [Abstract][Full Text] [Related]
15. The deubiquitinating enzyme UCHL3 promotes anaplastic thyroid cancer progression and metastasis through Hippo signaling pathway.
Tang J; Yang Q; Mao C; Xiao D; Liu S; Xiao L; Zhou L; Wu G; Tao Y
Cell Death Differ; 2023 May; 30(5):1247-1259. PubMed ID: 36813921
[TBL] [Abstract][Full Text] [Related]
16. Porphyromonas gingivalis promotes progression of esophageal squamous cell cancer via TGFβ-dependent Smad/YAP/TAZ signaling.
Qi YJ; Jiao YL; Chen P; Kong JY; Gu BL; Liu K; Feng DD; Zhu YF; Ruan HJ; Lan ZJ; Liu QW; Mi YJ; Guo XQ; Wang M; Liang GF; Lamont RJ; Wang H; Zhou FY; Feng XS; Gao SG
PLoS Biol; 2020 Sep; 18(9):e3000825. PubMed ID: 32886690
[TBL] [Abstract][Full Text] [Related]
17. FoxO4 negatively modulates USP10 transcription to aggravate the apoptosis and oxidative stress of hypoxia/reoxygenation-induced cardiomyocytes by regulating the Hippo/YAP pathway.
Huang J; Liu Y; Wang M; Wang R; Ling H; Yang Y
J Bioenerg Biomembr; 2021 Oct; 53(5):541-551. PubMed ID: 34251583
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
19. YY1 modulates the radiosensitivity of esophageal squamous cell carcinoma through KIF3B-mediated Hippo signaling pathway.
Zheng C; Li Z; Zhao C; Yin X; Feng L; Wang Z; Liu C; Li B
Cell Death Dis; 2023 Dec; 14(12):806. PubMed ID: 38065955
[TBL] [Abstract][Full Text] [Related]
20. USP18 promotes tumor metastasis in esophageal squamous cell carcinomas via deubiquitinating ZEB1.
Song C; Peng J; Wei Y; Shao J; Chen X; Zhang X; Xu J
Exp Cell Res; 2021 Dec; 409(1):112884. PubMed ID: 34743935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
